408 related articles for article (PubMed ID: 19196711)
1. Selectivity of docking sites in MAPK kinases.
Bardwell AJ; Frankson E; Bardwell L
J Biol Chem; 2009 May; 284(19):13165-73. PubMed ID: 19196711
[TBL] [Abstract][Full Text] [Related]
2. A docking site in MKK4 mediates high affinity binding to JNK MAPKs and competes with similar docking sites in JNK substrates.
Ho DT; Bardwell AJ; Abdollahi M; Bardwell L
J Biol Chem; 2003 Aug; 278(35):32662-72. PubMed ID: 12788955
[TBL] [Abstract][Full Text] [Related]
3. Interacting JNK-docking sites in MKK7 promote binding and activation of JNK mitogen-activated protein kinases.
Ho DT; Bardwell AJ; Grewal S; Iverson C; Bardwell L
J Biol Chem; 2006 May; 281(19):13169-13179. PubMed ID: 16533805
[TBL] [Abstract][Full Text] [Related]
4. Anthrax lethal factor-cleavage products of MAPK (mitogen-activated protein kinase) kinases exhibit reduced binding to their cognate MAPKs.
Bardwell AJ; Abdollahi M; Bardwell L
Biochem J; 2004 Mar; 378(Pt 2):569-77. PubMed ID: 14616089
[TBL] [Abstract][Full Text] [Related]
5. Mitogen-activated protein kinase (MAPK)-docking sites in MAPK kinases function as tethers that are crucial for MAPK regulation in vivo.
Grewal S; Molina DM; Bardwell L
Cell Signal; 2006 Jan; 18(1):123-34. PubMed ID: 15979847
[TBL] [Abstract][Full Text] [Related]
6. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.
Bardwell AJ; Abdollahi M; Bardwell L
Biochem J; 2003 Mar; 370(Pt 3):1077-85. PubMed ID: 12529172
[TBL] [Abstract][Full Text] [Related]
7. Two hydrophobic residues can determine the specificity of mitogen-activated protein kinase docking interactions.
Bardwell AJ; Bardwell L
J Biol Chem; 2015 Oct; 290(44):26661-74. PubMed ID: 26370088
[TBL] [Abstract][Full Text] [Related]
8. A novel retro-inverso peptide is a preferential JNK substrate-competitive inhibitor.
Ngoei KR; Catimel B; Milech N; Watt PM; Bogoyevitch MA
Int J Biochem Cell Biol; 2013 Aug; 45(8):1939-50. PubMed ID: 23792175
[TBL] [Abstract][Full Text] [Related]
9. A conserved docking motif in MAP kinases common to substrates, activators and regulators.
Tanoue T; Adachi M; Moriguchi T; Nishida E
Nat Cell Biol; 2000 Feb; 2(2):110-6. PubMed ID: 10655591
[TBL] [Abstract][Full Text] [Related]
10. Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7.
Fleming Y; Armstrong CG; Morrice N; Paterson A; Goedert M; Cohen P
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):145-54. PubMed ID: 11062067
[TBL] [Abstract][Full Text] [Related]
11. Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for activation of p38alpha and p38delta MAPK isoforms by TGF-beta 1 in murine mesangial cells.
Wang L; Ma R; Flavell RA; Choi ME
J Biol Chem; 2002 Dec; 277(49):47257-62. PubMed ID: 12374793
[TBL] [Abstract][Full Text] [Related]
12. A conserved docking site in MEKs mediates high-affinity binding to MAP kinases and cooperates with a scaffold protein to enhance signal transmission.
Bardwell AJ; Flatauer LJ; Matsukuma K; Thorner J; Bardwell L
J Biol Chem; 2001 Mar; 276(13):10374-86. PubMed ID: 11134045
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of MAPK cascades by insulin and osmotic shock: lack of an involvement of p38 mitogen-activated protein kinase in glucose transport in 3T3-L1 adipocytes.
Kayali AG; Austin DA; Webster NJ
Diabetes; 2000 Nov; 49(11):1783-93. PubMed ID: 11078444
[TBL] [Abstract][Full Text] [Related]
14. Selective targeting of MAPKs to the ETS domain transcription factor SAP-1.
Galanis A; Yang SH; Sharrocks AD
J Biol Chem; 2001 Jan; 276(2):965-73. PubMed ID: 11029469
[TBL] [Abstract][Full Text] [Related]
15. Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b.
Chang CI; Xu BE; Akella R; Cobb MH; Goldsmith EJ
Mol Cell; 2002 Jun; 9(6):1241-9. PubMed ID: 12086621
[TBL] [Abstract][Full Text] [Related]
16. JSAP1, a novel jun N-terminal protein kinase (JNK)-binding protein that functions as a Scaffold factor in the JNK signaling pathway.
Ito M; Yoshioka K; Akechi M; Yamashita S; Takamatsu N; Sugiyama K; Hibi M; Nakabeppu Y; Shiba T; Yamamoto KI
Mol Cell Biol; 1999 Nov; 19(11):7539-48. PubMed ID: 10523642
[TBL] [Abstract][Full Text] [Related]
17. Human mitogen-activated protein kinase kinase kinase mediates the stress-induced activation of mitogen-activated protein kinase cascades.
Chan-Hui PY; Weaver R
Biochem J; 1998 Dec; 336 ( Pt 3)(Pt 3):599-609. PubMed ID: 9841871
[TBL] [Abstract][Full Text] [Related]
18. Manganese modulation of MAPK pathways: effects on upstream mitogen activated protein kinase kinases and mitogen activated kinase phosphatase-1 in microglial cells.
Crittenden PL; Filipov NM
J Appl Toxicol; 2011 Jan; 31(1):1-10. PubMed ID: 20589745
[TBL] [Abstract][Full Text] [Related]
19. A bipartite mechanism for ERK2 recognition by its cognate regulators and substrates.
Zhang J; Zhou B; Zheng CF; Zhang ZY
J Biol Chem; 2003 Aug; 278(32):29901-12. PubMed ID: 12754209
[TBL] [Abstract][Full Text] [Related]
20. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
